Correlation Between Tarsus Pharmaceuticals and Tscan Therapeutics

Can any of the company-specific risk be diversified away by investing in both Tarsus Pharmaceuticals and Tscan Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Tarsus Pharmaceuticals and Tscan Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Tarsus Pharmaceuticals and Tscan Therapeutics, you can compare the effects of market volatilities on Tarsus Pharmaceuticals and Tscan Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Tarsus Pharmaceuticals with a short position of Tscan Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Tarsus Pharmaceuticals and Tscan Therapeutics.

Diversification Opportunities for Tarsus Pharmaceuticals and Tscan Therapeutics

-0.59

Correlation Coefficient

Tarsus Pharmaceuticals  Tscan Therapeutics

Excellent diversification

The 3 months correlation between Tarsus and Tscan is -0.59. Overlapping area represents the amount of risk that can be diversified away by holding Tarsus Pharmaceuticals and Tscan Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Tscan Therapeutics and Tarsus Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Tarsus Pharmaceuticals are associated (or correlated) with Tscan Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Tscan Therapeutics has no effect on the direction of Tarsus Pharmaceuticals i.e., Tarsus Pharmaceuticals and Tscan Therapeutics go up and down completely randomly.

Pair Corralation between Tarsus Pharmaceuticals and Tscan Therapeutics

Given the investment horizon of 90 days Tarsus Pharmaceuticals is expected to generate 0.56 times more return on investment than Tscan Therapeutics. However, Tarsus Pharmaceuticals is 1.78 times less risky than Tscan Therapeutics. It trades about 0.27 of its potential returns per unit of risk. Tscan Therapeutics is currently generating about -0.12 per unit of risk. If you would invest  3,170  in Tarsus Pharmaceuticals on September 12, 2024 and sell it today you would earn a total of  1,895  from holding Tarsus Pharmaceuticals or generate 59.78% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

Tarsus Pharmaceuticals  vs.  Tscan Therapeutics

Tarsus Pharmaceuticals

Risk-Adjusted Performance

21 of 100

Solid

Compared to the overall equity markets, risk-adjusted returns on investments in Tarsus Pharmaceuticals are ranked lower than 21 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively weak basic indicators, Tarsus Pharmaceuticals unveiled solid returns over the last few months and may actually be approaching a breakup point.

Tscan Therapeutics

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Tscan Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Pair Trading with Tarsus Pharmaceuticals and Tscan Therapeutics

The main advantage of trading using opposite Tarsus Pharmaceuticals and Tscan Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Tarsus Pharmaceuticals position performs unexpectedly, Tscan Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Tscan Therapeutics will offset losses from the drop in Tscan Therapeutics' long position.

The idea behind Tarsus Pharmaceuticals and Tscan Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Watchlist Optimization module to optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm.